1/ Medtronic acquires Fortimedix Surgical – This acquisition aimed to enhance Medtronic’s surgical portfolio, particularly in joint-type instruments and technologies for endoscopic, robotic, and minimally invasive surgeries.
2/ Enovis acquires LimaCorporate – Enovis completed its acquisition of LimaCorporate for approximately $844 million, significantly expanding Enovis’ reconstruction segment with the addition of custom 3D-printed implants and digital innovations.
Read more on OrthoStreams – Enovis acquires Lima for $850M (3 X sales)
3/ Zimmer Biomet acquires OrthoGrid Systems – Zimmer Biomet’s acquisition included OrthoGrid’s Hip AI surgical assistance platform along with two additional FDA-cleared orthopedic applications, focusing on enhancing surgical precision.
Read more on OrthoStreams – ZB acquires OrthoGrid for an undisclosed sum.
4/ Stryker acquires Artelon – Stryker completed its acquisition of Artelon, bolstering its sports medicine and foot and ankle product lines with Artelon’s soft tissue fixation technology.
Read more on OrthoStreams – Stryker acquires Artelon (rumors in the BoneChat community ~12X $25M in revenue = $300M acquisition price)
5/ OrthoPediatrics acquires Boston Orthotics & Prosthetics – This acquisition targeted pediatric orthotic management, expanding OrthoPediatrics’ capabilities in pediatric orthopedics.
Read more on OrthoStreams – OrthoPediatrics acquires a distressed Boston Orthotics & Prosthetics for $22M
6/ Smith+Nephew acquires CartiHeal – Smith+Nephew is set to acquire CartiHeal, known for its Agili-C technology aimed at cartilage regeneration in the knee, for $180 million, with potential earn-outs up to an additional $150 million based on future performance.
Read more on OrthoStreams – S+N acquires CartiHeal for $330M.
7/ HealthpointCapital acquires SteriCUBE – While not strictly an orthopedic company, this acquisition by a private equity firm involved a firm related to orthopedic device manufacturing technologies.
8/ RTI acquires Collagen Solutions – At a high level strategically, RTI Surgical’s acquisition of Collagen Solutions strengthens its position in the regenerative medicine market by expanding its soft tissue portfolio with advanced collagen-based biomaterials. This move enhances RTI’s access to high-growth clinical areas such as cardiac, sports medicine, and orthopedics, while accelerating innovation and development of new products for OEM customers. The acquisition supports RTI’s goal of providing innovative, patient-centered solutions and aligns with its growth strategy, backed by its main shareholder, Montagu.
Read more on OrthoStreams – RTI acquires Collagen Solutions
Historic acquisitions and multiples.
(average revenue multiples 2013-2023 = 12.1 X Multiplier)
Table provided by: Caira Surgical Investor Presentation
Website: www.cairasurgical.com
Pitch Video: https://youtu.be/3uDn6l9gXPw?si=V-n0qNcMU2sWEY0y